標(biāo)題: Titlebook: Dyslipidemias; Pathophysiology, Eva Abhimanyu Garg Book 2015 Humana Press 2015 Abetalipoproteinemia.Chronic kidney disease.Drug-induced dys [打印本頁] 作者: 憑票入場 時間: 2025-3-21 16:24
書目名稱Dyslipidemias影響因子(影響力)
書目名稱Dyslipidemias影響因子(影響力)學(xué)科排名
書目名稱Dyslipidemias網(wǎng)絡(luò)公開度
書目名稱Dyslipidemias網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Dyslipidemias被引頻次
書目名稱Dyslipidemias被引頻次學(xué)科排名
書目名稱Dyslipidemias年度引用
書目名稱Dyslipidemias年度引用學(xué)科排名
書目名稱Dyslipidemias讀者反饋
書目名稱Dyslipidemias讀者反饋學(xué)科排名
作者: 協(xié)定 時間: 2025-3-21 22:37
Interpreter und Arbeitsbereiche,sity lipoproteins (HDL) mediate the transport of cholesterol from the periphery back to the liver for excretion. Normal lipoprotein metabolism is essential for health, and a variety of inherited and acquired disorders disrupt normal lipoprotein metabolism and cause dyslipidemia and other consequence作者: fender 時間: 2025-3-22 00:56
https://doi.org/10.1007/978-1-84800-310-1 To date, there is only limited experience from Lp(a)-reducing therapy, and apart from nicotinic acid, Lp(a) levels are not impacted by conventional lipid-lowering therapy. Recent studies using novel therapeutic approaches show promise, as apoB antisense inhibitors and proprotein convertase subtilis作者: Ascribe 時間: 2025-3-22 08:26
Abdul Ghafur Hamid,Khin Maung Seinmia of T1D may evolve to be more consistent with that of peripheral hyperinsulinemia and relative euglycemia. Lipid and lipoprotein-related health with its effects on microvascular and macrovascular disease will continue to be an important aspect of health care in people with T1D.作者: Tempor 時間: 2025-3-22 10:00 作者: HALO 時間: 2025-3-22 15:51 作者: HALO 時間: 2025-3-22 18:17 作者: 范例 時間: 2025-3-22 22:11 作者: adhesive 時間: 2025-3-23 02:24 作者: 極肥胖 時間: 2025-3-23 05:36 作者: 華而不實(shí) 時間: 2025-3-23 10:20 作者: 粘 時間: 2025-3-23 14:05
Type 1 Diabetes Mellitus and Dyslipidemia,mia of T1D may evolve to be more consistent with that of peripheral hyperinsulinemia and relative euglycemia. Lipid and lipoprotein-related health with its effects on microvascular and macrovascular disease will continue to be an important aspect of health care in people with T1D.作者: 乳汁 時間: 2025-3-23 20:38 作者: 噴油井 時間: 2025-3-23 22:21
Primary Hypertriglyceridemia,ple common small-effect genetic variants—single-nucleotide polymorphisms—together with occasional heterozygous rare large-effect variants. Here, we discuss molecular genetic, clinical, and therapeutic aspects of the HTG disorders, except for familial combined hyperlipoproteinemia, which is discussed作者: 慢慢啃 時間: 2025-3-24 03:12
Lipodystrophies and Dyslipidemias,inly due to the destruction of adipocytes due to autoimmune mechanisms, drugs, or other unknown factors. Many patients develop extreme hypertriglyceridemia and chylomicronemia predisposing them to acute pancreatitis and thus need to be differentiated from those with type 1 hyperlipoproteinemia. Othe作者: 議程 時間: 2025-3-24 07:45 作者: V洗浴 時間: 2025-3-24 13:10
Nutrition and Coronary Heart Disease Prevention,n women. Vegetables, fruits, and whole grains are recommended. Many health professionals also recommend a regular intake of essential omega 3 and omega 6 fatty acids for the general population as the mainstay of coronary heart disease prevention. The focus of this chapter is to review the current di作者: 戲服 時間: 2025-3-24 15:15 作者: 津貼 時間: 2025-3-24 19:45
https://doi.org/10.1007/978-1-60761-424-1Abetalipoproteinemia; Chronic kidney disease; Drug-induced dyslipidemia; Dyslipidemia; Familial lipodyst作者: sinoatrial-node 時間: 2025-3-25 00:33 作者: FOLLY 時間: 2025-3-25 03:22
Julia A. Hubbard,Bing Xiao,Jon R. Wilsongher levels generally confer greater risk for cardiovascular disease (CVD) events. The key determinants for higher levels of atherogenic lipids measured as low-density lipoprotein cholesterol (LDL-C) include high dietary saturated fat, high dietary cholesterol, and low dietary polyunsaturated fat. T作者: 鉗子 時間: 2025-3-25 10:58 作者: Factorable 時間: 2025-3-25 14:34
Modelling Storm Surge Hazard to Mekong Deltating lipoprotein fractions, an individual’s CVD risk is also influenced by the concomitant presence or absence of other standard CVD risk factors. In this chapter, we describe the strengths and weaknesses of common circulating lipoproteins that are measured in clinical practice for predicting CVD ri作者: 青春期 時間: 2025-3-25 18:46
https://doi.org/10.1007/978-3-642-52438-7ong and internally consistent. Youth affected with dyslipidemia include those with single gene disorders such as familial hypercholesterolemia (FH), and those with oligogenic disorders such as familial combined hyperlipidemia (FCHL). In large populations of children followed up for several decades, 作者: 懸崖 時間: 2025-3-25 23:43
Frank Fischer,Katharina Fischer. Dyslipidemia in type 2 diabetes is characterized by elevated levels of plasma total and very-low-density lipoprotein triglycerides and postprandial triglyceride-rich lipoprotein remnants, abundance of small dense low-density lipoprotein (LDL) particles, low levels of HDL cholesterol, and elevated 作者: 枯萎將要 時間: 2025-3-26 02:05 作者: 畏縮 時間: 2025-3-26 06:24 作者: 轉(zhuǎn)向 時間: 2025-3-26 11:26
Mumita Tanjeela,Md. Anisur RahmanUntreated HIV infection results in an initial fall of high-density lipoprotein (HDL) cholesterol, followed by declines in non-HDL cholesterol fractions. With progression to the acquired immune deficiency syndrome (AIDS), serum triglyceride levels rise. These changes appear principally driven by infl作者: 啟發(fā) 時間: 2025-3-26 12:52
Peter Bühler,Patrick Schlaich,Dominik Sinnerlesterol and a high risk of premature cardiovascular disease (CVD). There are autosomal dominant and recessive MHs, although the latter are very rare. The most common and best studied MH is familial hypercholesterolemia (FH), an autosomal codominant disease caused by mutations in the LDL receptor ge作者: 防水 時間: 2025-3-26 20:10 作者: EVICT 時間: 2025-3-27 00:27 作者: 燈絲 時間: 2025-3-27 04:51
,Schriftgutorganisation — lohnt sich das?,pies that can prevent or ameliorate the complications are increasingly available. Thus, genetic defects that were thought previously to be exoteric or where no treatments could be offered are now beginning to populate the treatable spectrum of disease. These diseases, by definition of being rare, af作者: Collar 時間: 2025-3-27 07:16 作者: BILE 時間: 2025-3-27 12:39
,Gebet an Selene (VII 756–794),ipid metabolism leading to dyslipidemia. These include antihypertensives such as thiazide diuretics and nonspecific beta-adrenergic blockers, various steroid hormones including glucocorticoids, estrogens, androgens, and their related compounds, immunosuppressive medications, antineoplastic agents, a作者: Hormones 時間: 2025-3-27 16:42 作者: Corroborate 時間: 2025-3-27 18:53 作者: 觀察 時間: 2025-3-27 21:56
Emily Jin-Jy Shieh,Sheng-Ju Chanof Health. These guidelines were produced by the National Cholesterol Education Program. From this program, an Adult Treatment Panel (ATP) has organized the major sets of guidelines. Three reports were issued by ATP. The third and last was updated by a smaller panel in 2004. More recently, the Natio作者: arcane 時間: 2025-3-28 03:17
Leyla Dakhli,Pascale Laborier,Frank Wolffsodium to
作者: 約會 時間: 2025-3-28 10:00 作者: 光亮 時間: 2025-3-28 10:59 作者: INCUR 時間: 2025-3-28 16:08 作者: stressors 時間: 2025-3-28 20:03 作者: 案發(fā)地點(diǎn) 時間: 2025-3-29 00:35
Epidemiology of Blood Lipids and Lipoproteins,gher levels generally confer greater risk for cardiovascular disease (CVD) events. The key determinants for higher levels of atherogenic lipids measured as low-density lipoprotein cholesterol (LDL-C) include high dietary saturated fat, high dietary cholesterol, and low dietary polyunsaturated fat. T作者: watertight, 時間: 2025-3-29 06:45 作者: 顯赫的人 時間: 2025-3-29 08:46
Lipoproteins and Cardiovascular Disease Risk,ting lipoprotein fractions, an individual’s CVD risk is also influenced by the concomitant presence or absence of other standard CVD risk factors. In this chapter, we describe the strengths and weaknesses of common circulating lipoproteins that are measured in clinical practice for predicting CVD ri作者: 控訴 時間: 2025-3-29 15:14 作者: FLOUR 時間: 2025-3-29 17:02
Type 2 Diabetes Mellitus and Dyslipidemia,. Dyslipidemia in type 2 diabetes is characterized by elevated levels of plasma total and very-low-density lipoprotein triglycerides and postprandial triglyceride-rich lipoprotein remnants, abundance of small dense low-density lipoprotein (LDL) particles, low levels of HDL cholesterol, and elevated 作者: 有危險 時間: 2025-3-29 22:16
Type 1 Diabetes Mellitus and Dyslipidemia,k factor. The pathophysiology of dyslipidemia in T1D is frequently a function of insulin deficiency and poor glycemic control or peripheral hyperinsulinization in intensive control (with obesity as a potential contributor). As such, intensive diabetes control to achieve near euglycemia with a health作者: 不安 時間: 2025-3-30 03:42
Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome,idney disease and proteinuria are associated with cardiovascular disease and profound alteration of lipid metabolism and serum lipid and lipoprotein profile. The associated lipid disorders play a major role in progression of renal and cardiovascular disease in this population. The nature and mechani作者: 1分開 時間: 2025-3-30 04:48 作者: 水汽 時間: 2025-3-30 11:59
Monogenic Hypercholesterolemias,lesterol and a high risk of premature cardiovascular disease (CVD). There are autosomal dominant and recessive MHs, although the latter are very rare. The most common and best studied MH is familial hypercholesterolemia (FH), an autosomal codominant disease caused by mutations in the LDL receptor ge作者: BROTH 時間: 2025-3-30 15:24
Primary Hypertriglyceridemia,terns of inheritance. The exception is “familial chylomicronemia,” in which severe HTG results from autosomal recessive inheritance rare loss-of-function mutations in genes such as lipoprotein lipase (.), apolipoprotein C-II (.), apolipoprotein A-V (.), lipase maturation factor 1 (.), and glycosyl-p作者: Relinquish 時間: 2025-3-30 18:25 作者: Obedient 時間: 2025-3-30 22:15 作者: nascent 時間: 2025-3-31 01:07
Genetic Abetalipoproteinaemia and Hypobetalipoproteinaemia, of the condition, together with the severity of the mutation or mutations present. These disorders may or may not be associated with clinical manifestations such as fat malabsorption, growth failure, fat-soluble vitamin deficiency, fatty liver disease, and neuro-ophthalmological dysfunction. We hav作者: Incorporate 時間: 2025-3-31 05:00 作者: Interdict 時間: 2025-3-31 11:26
Lipodystrophies and Dyslipidemias,o developing insulin resistance and its complications such as premature diabetes mellitus, hypertriglyceridemia, low levels of high-density lipoprotein (HDL) cholesterol, and nonalcoholic hepatic steatosis. The severity of metabolic complications in general parallels the extent of body fat loss, and作者: 美麗的寫 時間: 2025-3-31 14:56 作者: 減弱不好 時間: 2025-3-31 18:30
Perspectives on Cholesterol Guidelines,of Health. These guidelines were produced by the National Cholesterol Education Program. From this program, an Adult Treatment Panel (ATP) has organized the major sets of guidelines. Three reports were issued by ATP. The third and last was updated by a smaller panel in 2004. More recently, the Natio作者: Middle-Ear 時間: 2025-3-31 23:48
Nutrition and Coronary Heart Disease Prevention,sodium to
作者: Contort 時間: 2025-4-1 03:05 作者: 舊病復(fù)發(fā) 時間: 2025-4-1 07:57 作者: 得罪人 時間: 2025-4-1 11:21
Type 2 Diabetes Mellitus and Dyslipidemia,levels of apolipoprotein B. High levels of LDL cholesterol is the most important modifiable risk factor for CVD in type 2 diabetes, and therefore statin treatment, in addition to diet, is the basis of lipid-lowering treatment. Statin treatment is evidence-based in the prevention of CVD mortality and morbidity in individuals with type 2 diabetes作者: 膽小懦夫 時間: 2025-4-1 17:08
Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome,sms of lipid abnormalities in kidney disease vary depending on the presence and severity of proteinuria, renal failure, renal replacement modalities (hemodialysis, peritoneal dialysis, and renal transplantation), dietary and drug regimens, and preexistent genetic disorders of lipid metabolism.
